Point mutations of the K-RAS gene at codon 12 are found in about 40% of cases with colorectal cancer. The diagnostic implications of the detection of these mutations and their clinical utility are still unclear. The aim of this study was to test both the feasibility of the detection of the mutated K-RAS gene in serum and its potential role in colorectal cancer detection and monitoring.
Codon 12 K-RAS mutations were examined in DNA extracted from the serum of 35 patients with colorectal cancer and were compared with the K-RAS status in the corresponding primary tumor. Molecular detection was performed by the mutant-enriched PCR (ME-PCR) assay, a sensitive method capable of distinguishing a small quantity of mutated DNA in the presence of abundant wild-type DNA. The occurrence of mutations was compared with clinicopathological parameters as well as CEA and CA19.9 serum levels.
We found codon 12 K-RAS mutations in the tissue of 13/35 (37%) patients. Serum mutations were detected in 5/13 (38.5%) patients with mutated K-RAS in the tissue. 26/35 (74%) patients showed an identical K-RAS pattern in tissue and serum. No codon 12 K-RAS alterations were found in serum samples of 22 patients with benign gastrointestinal diseases. Elevated serum CEA levels were detected in 16 patients, four of whom also presented serum RAS mutations.
Our results confirm that K-RAS mutations can be found in circulating DNA extracted from serum samples of patients with colorectal cancer and show that there is a correspondence between serum and tissue K-RAS patterns.
ConejoJ.R., ParraT., CanteroM.Detection of H-ras mutations in urine sediments by a mutant-enriched PCR technique.Clin Chem1998; 44: 1570–2.
2.
TakedaS., IshiiA., NakamuraY.Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA).Hum Mut1993; 2: 112–7.
3.
MaoL., HrubanR.H., BoyleJ.O., TockmanM., SidranskyD.Detection of oncogene mutations in sputum precedes diagnosis of lung cancer.Cancer Res1994; 54: 1634–7.
4.
SomersV.A., PietersenA.M., TheunissenP.H., ThunnissenF.B.Detection of K-ras point mutations in sputum from patients with adenocarcinoma of the lung by Point-EXACCT.J Clin Oncol1998; 16: 3061–8.
5.
TobiM., LuoF.C., RonaiZ.Detection of K-ras mutation in colonic effluent samples from patients without evidence of colorectal carcinoma.J Natl Cancer Inst1994; 86: 1007–10.
6.
ItoR., TamuraK., AshidaH.Usefulness of K-ras gene mutation at codon 12 in bile for diagnosing biliary structure.Int J Oncol1998; 12: 1019–23.
7.
YamashitaK., KidaY., ShinodaH., OkayasuI.K-ras point mutations in the supernatants of pancreatic juice and bile are reliable for diagnosis of pancreas and biliary tract carcinomas complementary to cytologic examination.J Cancer Res1999; 90: 240–8.
8.
HasegawaY., TakedaS., IchiiS.Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumours by mutant-allele-specific amplification (MASA).Oncogene1995; 10: 1441–5.
9.
Smith-RavinJ., EnglandJ., TalbotC., BodmerW.Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients.Gut1995; 36: 81–6.
10.
NollauP., MoserC., WeinlandG., WagenerC.Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR.Int J Cancer1996; 66: 332–6.
11.
SoresonG.D., PribishD.M., ValoneF.H., MemoliV.A., BzikD.J., YaoS.L.Soluble normal and mutated DNA sequences from single-copy genes in human blood.Cancer Epidemiol Biomark Prev1994; 3: 67–71.
12.
ShapiroB., ChakrabartyM., CohnE., LeonS.Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease.Cancer1983; 51: 1127–9.
13.
StrounM., AnkerP., MauriceP., LyauteyJ., LederreyC., BeljanskiM.Neoplastic characteristics of the DNA found in the plasma of cancer patients.Oncology1989; 46: 318–22.
14.
ChenX.Q., StrounM., MagnenatJ.L.Microsatellite alterations in plasma DNA of small cell lung cancer patients.Nat Med1996; 2: 1033–5.
15.
NawrozH., KochW., AnkerP., StrounM., SidranskyD.Microsatellite alterations in serum DNA of head and neck cancer patients.Nat Med1996; 2: 1035–7.
16.
TadaM., OmataM., KawaiS.Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.Cancer Res1993; 53: 2472–4.
17.
MulcahyH.E., LyauteyJ., LederreyC.A prospective study of K-ras mutations in the plasma of pancreatic cancer patients.Clin Cancer Res1998; 4: 271–5.
18.
YamadaT., NakamoriS., OhzatoH.Detection of K-ras mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.Clin Cancer Res1998; 4: 1527–32.
19.
CastellsA., PuigP., MoraJ.K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance.J Clin Oncol1999, 17: 578–84.
20.
TheodorL., MelzerE., SologovM., IdelmanG., FriedmanE., Bar-MeirS.Detection of pancreatic carcinoma. Diagnostic value of K-ras mutations in circulating DNA from serum.Digest Dis Sci1999; 44: 2014–9.
21.
AnkerP., LefortF., VasioukhinV.K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer.Gastroenterology1997; 112: 1114–20.
22.
De KokJ.B., Van SolingeW.W., RuersT.J.M.Detection of tumour DNA in serum of colorectal cancer patients.Scand J Clin Lab Invest1997; 57: 601–4.
23.
KopreskiM.S., BenkoF.A., KweeC.Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer.Br J Cancer1997; 76: 1293–9.
24.
HibiK., RobisonC.R., BookerS.Molecular detection of genetic alterations in the serum of colorectal cancer patients.Cancer Res1998; 58: 1405–7.
FearonE.R., VogelsteinB.A genetic model for colorectal tumorigenesis.Cell1990; 61: 759–67.
27.
ChoK.R., VogelsteinB.Genetic alterations in the adenomacarcinoma sequence.Cancer1992; 70: 1727–31.
28.
VogelsteinB., KinzlerK.W.The multistep nature of cancer.Trends Genet1993; 9: 138–41.
29.
IlyasM., StraubJ., TomlinsonI.P.M., BodmerW.F.Genetic pathways in colorectal and other cancers.Eur J Cancer1999; 35: 335–51.
30.
BosJ.L., FearonE.R., HamiltonS.R.Prevalence of ras gene mutations in human colorectal cancers.Nature1987; 327: 293–7.
31.
BosJ.L.Ras oncogenes in human cancer: A review.Cancer Res1989; 49: 4682–9.
32.
Laurent-PuigP., OlschwangS., DelattreO.Survival and acquired genetic alterations in colorectal cancer.Gastroenterology1992; 102: 1136–41.
33.
BreivikJ., MelingG.I., SpurklendA., RognumT.O., GaudernackG.K-ras mutation in colorectal cancer – relations to patient age, sex and tumour location.Br J Cancer1994; 69: 367–71.
34.
AndreyevH.J.N., NormanA.R., CunninghamD., OatesJ.R., ClarkeP.A.Kirsten ras mutations in patients with colorectal cancer: the multicenter “RASCAL” study.J Natl Cancer Inst1998; 90: 675–84.
35.
KwokS., HiguchiR.Avoiding false positives with PCR.Nature1989; 339: 237–8.
36.
BurchillS.A., BradburyM.F., PittmanK.Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction.Br J Cancer1995; 71: 1368–72.
37.
HardinghamJ.E., KotasekD., SageR.E.Detection of circulating tumour cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease.Mol Med1995; 1: 789–94.
38.
CastellsA., BoixL., BessaX.Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction.Br J Cancer1998; 78: 1368–72.
39.
VasioukhinV., AnkerP., MauriceP., LyauteyJ., LederreyC., StrounM.Point mutations of the N-ras in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogeneous leukaemia.Br J Haematol1994; 86: 774–9.
40.
VasioukhinV., StrounM., MauriceP., LyauteyJ., LederreyC., AnkerP.K-ras point mutations in the blood plasma DNA of patients with colorectal tumour. In: Verna R, Shamoo A, eds. Challenges of modern medicine.Rome: Ares-Serono Symposia Publications, Biotechnology Today1994; 5: 141–50.
41.
LeonS.A., ShapiroB., SklaroffD.M., YarosM.J.Free DNA in the serum of cancer patients and the effect of therapy.Cancer Res1977; 37: 646–50.
42.
ThibodeauS.N., BrenG., SchaidD.Microsatellite instability in cancer of the proximal colon.Science1993; 260: 816–9.
43.
LeviS., Urbano-IspizuaA., GillR.Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique.Cancer Res1991; 51: 3497–502.
44.
KahnS.M., JiangW., CulbertsonT.A.Rapid and sensitive non-radioactive detection of mutant K-ras genes via 'enriched’ PCR amplification.Oncogene1991; 6: 1079–83.
45.
IonovY., PeinadoM.A., MalkhosyanS., ShibataD., PeruchoM.Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis.Nature1993; 363: 558–61.
46.
HeinenC.D., RichardsonD., WhiteR., GrodenJ.Microsatellite instability in colorectal adenocarcinoma cell lines that have full length adenomatous polyposis coli protein.Cancer Res1995; 55: 4797–9.
47.
RowinskyE.K., WindleJ.J., Von HoffD.D.RAS protein farnesyltransferase: a strategic target for anticancer therapeutic development.J Clin Oncol1999; 17: 3631–52.
